N-[[4-(5-cyclohexyloxy-4-methylpyrimidin-2-yl)-1-methylpyrazol-5-yl]methyl]-4-(2,2-difluoropropoxy)pyrimidin-2-amine

C23H29F2N7O2 — CID 175903097

IUPACN-[[4-(5-cyclohexyloxy-4-methylpyrimidin-2-yl)-1-methylpyrazol-5-yl]methyl]-4-(2,2-difluoropropoxy)pyrimidin-2-amine
SMILESCc1nc(-c2cnn(C)c2CNc2nccc(OCC(C)(F)F)n2)ncc1OC1CCCCC1
InChIInChI=1S/C23H29F2N7O2/c1-15-19(34-16-7-5-4-6-8-16)13-27-21(30-15)17-11-29-32(3)18(17)12-28-22-26-10-9-20(31-22)33-14-23(2,24)25/h9-11,13,16H,4-8,12,14H2,1-3H3,(H,26,28,31)
InChIKeyLMZXSQGYDIDDDZ-UHFFFAOYSA-N
MW473.53 g/mol
LogP4.33
Rot. Bonds9

About N-[[4-(5-cyclohexyloxy-4-methylpyrimidin-2-yl)-1-methylpyrazol-5-yl]methyl]-4-(2,2-difluoropropoxy)pyrimidin-2-amine

N-[[4-(5-cyclohexyloxy-4-methylpyrimidin-2-yl)-1-methylpyrazol-5-yl]methyl]-4-(2,2-difluoropropoxy)pyrimidin-2-amine (PubChem CID 175903097) has the molecular formula C23H29F2N7O2 and a molecular weight of 473.53 g/mol. Its IUPAC name is N-[[4-(5-cyclohexyloxy-4-methylpyrimidin-2-yl)-1-methylpyrazol-5-yl]methyl]-4-(2,2-difluoropropoxy)pyrimidin-2-amine.

Molecular Properties

Compound NameN-[[4-(5-cyclohexyloxy-4-methylpyrimidin-2-yl)-1-methylpyrazol-5-yl]methyl]-4-(2,2-difluoropropoxy)pyrimidin-2-amine
PubChem CID175903097
Molecular FormulaC23H29F2N7O2
Molecular Weight473.53 g/mol
Exact Mass473.24
IUPAC NameN-[[4-(5-cyclohexyloxy-4-methylpyrimidin-2-yl)-1-methylpyrazol-5-yl]methyl]-4-(2,2-difluoropropoxy)pyrimidin-2-amine
SMILESCc1nc(-c2cnn(C)c2CNc2nccc(OCC(C)(F)F)n2)ncc1OC1CCCCC1
InChIInChI=1S/C23H29F2N7O2/c1-15-19(34-16-7-5-4-6-8-16)13-27-21(30-15)17-11-29-32(3)18(17)12-28-22-26-10-9-20(31-22)33-14-23(2,24)25/h9-11,13,16H,4-8,12,14H2,1-3H3,(H,26,28,31)
InChIKeyLMZXSQGYDIDDDZ-UHFFFAOYSA-N
XLogP4.33
TPSA99.87 Ų
H-Bond Donors1
H-Bond Acceptors9
Rotatable Bonds9
Heavy Atoms34
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500473.53
LogP ≤ 54.33
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 109

Analyze N-[[4-(5-cyclohexyloxy-4-methylpyrimidin-2-yl)-1-methylpyrazol-5-yl]methyl]-4-(2,2-difluoropropoxy)pyrimidin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[[4-(5-cyclohexyloxy-4-methylpyrimidin-2-yl)-1-methylpyrazol-5-yl]methyl]-4-(2,2-difluoropropoxy)pyrimidin-2-amine?
The IUPAC name of N-[[4-(5-cyclohexyloxy-4-methylpyrimidin-2-yl)-1-methylpyrazol-5-yl]methyl]-4-(2,2-difluoropropoxy)pyrimidin-2-amine (CID 175903097) is N-[[4-(5-cyclohexyloxy-4-methylpyrimidin-2-yl)-1-methylpyrazol-5-yl]methyl]-4-(2,2-difluoropropoxy)pyrimidin-2-amine.
What is the SMILES notation for N-[[4-(5-cyclohexyloxy-4-methylpyrimidin-2-yl)-1-methylpyrazol-5-yl]methyl]-4-(2,2-difluoropropoxy)pyrimidin-2-amine?
The canonical SMILES for N-[[4-(5-cyclohexyloxy-4-methylpyrimidin-2-yl)-1-methylpyrazol-5-yl]methyl]-4-(2,2-difluoropropoxy)pyrimidin-2-amine is Cc1nc(-c2cnn(C)c2CNc2nccc(OCC(C)(F)F)n2)ncc1OC1CCCCC1.
What is the InChIKey of N-[[4-(5-cyclohexyloxy-4-methylpyrimidin-2-yl)-1-methylpyrazol-5-yl]methyl]-4-(2,2-difluoropropoxy)pyrimidin-2-amine?
The InChIKey is LMZXSQGYDIDDDZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H29F2N7O2/c1-15-19(34-16-7-5-4-6-8-16)13-27-21(30-15)17-11-29-32(3)18(17)12-28-22-26-10-9-20(31-22)33-14-23(2,24)25/h9-11,13,16H,4-8,12,14H2,1-3H3,(H,26,28,31).
What are the key properties of N-[[4-(5-cyclohexyloxy-4-methylpyrimidin-2-yl)-1-methylpyrazol-5-yl]methyl]-4-(2,2-difluoropropoxy)pyrimidin-2-amine?
N-[[4-(5-cyclohexyloxy-4-methylpyrimidin-2-yl)-1-methylpyrazol-5-yl]methyl]-4-(2,2-difluoropropoxy)pyrimidin-2-amine has a molecular weight of 473.53 g/mol, XLogP of 4.33, 9 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[4-(5-cyclohexyloxy-4-methylpyrimidin-2-yl)-1-methylpyrazol-5-yl]methyl]-4-(2,2-difluoropropoxy)pyrimidin-2-amine is sourced from PubChem (CID 175903097), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).